MEDTRONIC HEART VALVES DIVISION MEDTRONIC TRANSCATHETER VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
|
Back to Search Results |
|
Model Number MDT-TRANS VALVE |
Device Problems
Inadequacy of Device Shape and/or Size (1583); Migration (4003)
|
Patient Problems
Stroke/CVA (1770); Non specific EKG/ECG Changes (1817); Cardiovascular Insufficiency (4445); Aortic Valve Insufficiency/ Regurgitation (4450)
|
Event Date 11/19/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Citation: nuis et al.Balloon expandable vs.Self-expanding transcatheter valve for degenerated bioprosthesis: design and rationale of the baseline trial.Am heart j.2023 feb;256:139-147.Doi: 10.1016/j.Ahj.2022.11.013.Earliest date of publication used for date of event.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information via literature regarding balloon expandable vs.Self-expanding transcatheter valve as valve-in-valve implants for degenerated bioprostheses. data collection from 50 centers was initiated in november 2021, however the results were not yet available. multiple manufacturer¿s devices were implanted in the study population; an unspecified number of patients were implanted with a medtronic evolut pro+ bioprosthetic valve. no unique device identifier numbers were provided.In a meta-analysis review of 10 previously published studies, 30-day and 1-year mortalities occurred. no further details were provided on the deaths. there was no statement of causal or contributory relationship between medtronic product and the deaths.Additionally, these adverseevents were observed: valve migration requiring second valve implant, coronary occlusion, stroke, arrhythmia requiring permanent pacemaker implant, mean gradient > 20 mmhg, severe patient-prosthesis mismatch (ppm), and moderate to severe aortic regurgitation (ar). based on the available information medtronic product may have been associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
|
|
Search Alerts/Recalls
|
|
|